Brogan Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$702K Buy
1,806
+65
+4% +$25.9K 0.26% 25
2026
Q2
$673K Buy
1,741
+37
+2% +$13.7K 0.27% 22
2026
Q1
$499K Buy
1,704
+10
+0.6% +$3.29K 0.22% 27
2025
Q4
$594K Buy
1,694
+8
+0.5% +$2.7K 0.26% 23
2025
Q3
$545K Buy
1,686
+9
+0.5% +$2.8K 0.23% 27
2025
Q2
$652K Buy
1,677
+7
+0.4% +$2.82K 0.29% 19
2025
Q1
$726K Buy
1,670
+7
+0.4% +$2.81K 0.35% 16
2024
Q4
$613K Buy
1,663
+7
+0.4% +$2.93K 0.3% 15
2024
Q3
$861K Buy
1,656
+6
+0.4% +$3.2K 0.49% 13
2024
Q2
$894K Buy
1,650
+5
+0.3% +$2.64K 0.56% 12
2024
Q1
$853K Buy
1,645
+5
+0.3% +$2.49K 0.56% 13
2023
Q4
$773K Buy
1,640
+5
+0.3% +$2.31K 0.57% 12
2023
Q3
$712K Hold
1,635
– – 0.63% 11
2023
Q2
$726K Hold
1,635
– – 0.62% 11
2023
Q1
$752K Hold
1,635
– – 0.65% 10
2022
Q4
$839K Buy
+1,635
New +$830K 0.75% 8

Other funds holding ELV

Brogan Financial's ELV Position: Q3 2026 in Review

Brogan Financial increased its Elevance Health (ELV) stake by 3.7% in Q3 2026, buying an estimated $25.9K and bringing the position to 1,806 shares worth $702K. The position accounts for 0.26% of the portfolio, ranked #25.

Brogan Financial first reported a position in ELV in Q4 2022 and has held it in 16 quarters since. The position peaked at $894K in Q2 2024. 1,625 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Brogan Financial held 1,806 shares of Elevance Health worth $702K as of Q3 2026.
  • Brogan Financial bought 65 Elevance Health shares in Q3 2026, an estimated $25.9K.
  • Elevance Health made up 0.26% of Brogan Financial's portfolio in Q3 2026, its #25 holding.
  • Brogan Financial first reported a position in Elevance Health in Q4 2022 and has held it in 16 quarters since.
  • Brogan Financial's Elevance Health position peaked at $894K in Q2 2024.
  • 1,625 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Brogan Financial's 13F filing for Q3 2026, filed 12 Nov 2026.